Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Monday, March 11, 2019 at 4:00 PM to 4:30 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Citing this Article

Right click to copy or hit: ctrl+c (cmd+c on mac)

Published on 18.08.16 in Vol 5, No 3 (2016): Jul-Sept

This paper is in the following e-collection/theme issue:

Works citing "Designing an Adverse Drug Event Reporting System to Prevent Unintentional Reexposures to Harmful Drugs: Study Protocol for a Multiple Methods Design"

According to Crossref, the following articles are citing this article (DOI 10.2196/resprot.5967):

(note that this is only a small subset of citations)

  1. Lee CY, Chen YP. Machine learning on adverse drug reactions for pharmacovigilance. Drug Discovery Today 2019;24(7):1332
  2. Small SS, Hohl CM, Balka E. Organizational implications of implementing a new adverse drug event reporting system for care providers and integrating it with provincial health information systems. Healthcare Management Forum 2019;32(4):208
  3. Peddie D, Small SS, Badke K, Bailey C, Balka E, Hohl CM. Adverse Drug Event Reporting From Clinical Care: Mixed-Methods Analysis for a Minimum Required Dataset. JMIR Medical Informatics 2018;6(2):e10248
  4. Hohl CM, Small SS, Peddie D, Badke K, Bailey C, Balka E. Why Clinicians Don’t Report Adverse Drug Events: Qualitative Study. JMIR Public Health and Surveillance 2018;4(1):e21
  5. Small S, Peddie D, Ackerley C, Hohl C, Balka E. Patient experiences with informational discontinuity of care: Bridging the gaps. Procedia Computer Science 2017;113:295
  6. Chruscicki A, Badke K, Peddie D, Small S, Balka E, Hohl CM. Pilot-testing an adverse drug event reporting form prior to its implementation in an electronic health record. SpringerPlus 2016;5(1)